Great Point Partners LLC Amylyx Pharmaceuticals, Inc. Transaction History
Great Point Partners LLC
- $121 Million
- Q2 2025
A detailed history of Great Point Partners LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 2,000,000 shares of AMLX stock, worth $27.9 Million. This represents 10.64% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 1,811,996
10.38%
Holding current value
$27.9 Million
Previous $6.41 Million
99.88%
% of portfolio
10.64%
Previous 3.97%
Shares
5 transactions
Others Institutions Holding AMLX
# of Institutions
149Shares Held
76.1MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$123 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$110 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$82.8 Million7.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$63.2 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$62.7 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $815M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...